Market Overview

Cancer Genetics (NASDAQ: CGIX)

0.15 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:
-0.01
1.525M



Q1 2020
After-Hours
EPS:
REV:
-0.90
6.839M



Q4 2019
Pre-Market
EPS:
REV:
-0.14
6.8M



Q3 2019
After-Hours
EPS:
REV:
-0.31
5.94M



Q2 2019
Pre-Market
EPS:
REV:
-0.13
7.036M

-0.01
1.525M

Q1 2019
After-Hours
EPS:
REV:
-0.16
7.667M

10.77M
-0.90
6.839M

-36.5%
Q4 2018
Pre-Market
EPS:
REV:
-0.36
7.523M
-0.16
6.3M
-0.14
6.8M
12.5%
7.94%
Q3 2018
After-Hours
EPS:
REV:
-0.16
8.028M

7.57M
-0.31
5.94M

-21.53%
Q2 2018
Pre-Market
EPS:
REV:
-0.16
6.604M
-0.16
8.3M
-0.13
7.036M
-18.75%
-15.23%
Q1 2018
Pre-Market
EPS:
REV:
-0.11
6.966M
-0.13
8.2M
-0.16
7.667M
23.08%
-6.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!